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Abstract
OBJECTIVE: To investigate a quantitative method
for using radial artery pulse waveforms to assess
the effect of pulsatile flow during cardiopulmonary
bypass (CPB).
METHODS: A total of 34 adults with heart disease
who underwent open-heart surgery between April
2010 and January 2011 were randomized into a pul-
satile perfusion group (n=17) and a non-pulsatile
perfusion group (n=17). Radial arterial pulse wave-
forms of pulsatile and non-pulsatile perfusion pa-
tients were observed and compared before and
during CPB.
RESULTS: No pulse waveform could be detected at
patients' radial artery in both groups when the aor-
ta was cross-clamped. Pulse waveforms could be
detected at pulsatile perfusion patients' radial ar-
tery, but could not be detected at non-pulsatile per-
fusion patients' radial artery during CPB. Additional-
ly, patients' pulse waveforms during pulsatile perfu-
sion were lower than those before the operation.
CONCLUSION: Our findings indicate that radial ar-
tery sphygmogram can be used as a valid indicator
to evaluate the effectiveness of pulsatile perfusion
during CPB.
© 2014 JTCM. All rights reserved.
Key words: Cardiopulmonary bypass; Pulsatile
flow; Radial artery; Pulse waveforms; Sphygmogram
INTRODUCTION
Numerous experimental and clinical publications have
reported that pulsatile flow could significantly improve
the blood flow of such vital organs as the brain,1-4 heart,5
liver,6 pancreas,7,8 kidney,9,10 and gastrointestinal system;
11 reduce systemic inflammatory response;12,13 and de-
crease the incidence of postoperative deaths in pediat-
ric patients.14 However, to date there has been no com-
mon definition or criteria established for pulsatile flow,
resulting in ongoing disagreement and uncertainty in
the field.15 As techniques in detecting and analyzing
pulse waveforms of the radial artery over the past few
decades, new methods of determining radial artery
pressure flow have been established; such advances may
prove helpful in measuring pulsatile flow during cardio-
pulmonary bypass (CPB) procedures. In this study, we
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sought to investigate a quantitative method for pulsa-
tile flow with radial artery pulse waveforms during
CPB: pulsatile perfusion versus nonpulsatile perfusion.
MATERIALS ANDMETHODS
Patients
We conducted a study from April 2010 to January
2011 on 34 adult patients (including 2 cases of congen-
ital heart disease, 28 cases of rheumatic valvular heart
disease and 4 cases of coronary atherosclerotic disease)
who underwent open-heart surgeries at the Shanghai
Chest Hospital Affiliated with Shanghai Jiaotong Uni-
versity. Studied surgical cases comprised 2 cases of con-
genital heart disease, 28 cases of rheumatic valvular
heart disease, and 4 cases of coronary atherosclerotic
disease. Patients were prospectively randomized into a
pulsatile perfusion group (n=17) and a non-pulsatile
perfusion group (n=17) using computer-generated
numbering. The randomized treatment assignments
were sealed in opaque envelopes and were opened indi-
vidually for each patient.
All patients provided written informed consent prior
to study participation. Participation in the study did
not affect the standard of care provided to patients.
The study was approved by Shanghai University of
Traditional Chinese Medicine's clinical medical ethics
committee.
CPB Technique
The CPB circuit used in this study included a Stockert
S5 blood pump (Sorin Group, Munich, Germany); a
Trillium Affinity-541T hollow-fiber membrane oxy-
genator (Medtronic, Inc., Minneapolis, MN, USA); an
arterial filter (Ningbo Fly Medical Healthcare Co.,
Ltd., Ningbo, China); and a 24F arterial cannula
(Shanghai Xiangsheng Medical Apparatus Factory,
Shanghai, China).
In the pulsatile perfusion group, pulsatile flow was pro-
duced with the fixed pulse rate of 75 beats per minute
(bpm) by changing the rotational rate of the roller
pump and setting the baseflow (20%-30% of the equiv-
alent continuous flow), start time (20%-30% of the in-
terval), and stop time (70%-80% of the interval), until
two or three upward wave groups could be detected at
patients' radial artery (see the pump setting diagram
for pulsatile perfusion shown in Figure 1). Pulsatile per-
fusion was applied continuously during the aortic
cross-clamping period until aortic cross-clamping was
released and heartbeat resumed. In the non-pulsatile
perfusion group, non-pulsatile blood flow obtained
with a standard CPB circuit was 2.2-2.41 (m2)-1·min-1.
CPB was performed at a tepid temperature (nasopha-
ryngeal temperature: 34℃).
Sphygmograms
In recent years, the DDMX-100 sphygmograph
[Shanghai University of Traditional Chinese Medicine
(TCM) Science and Technology Co., Ltd., Shanghai,
China] was developed and patented in China (No.
200520038993.8). The sphygmogram apparatus com-
prises a pulse sensor (see the schematic diagram of the
structure shown in Figure 2), a signal amplifier, an A/
D converter, a recorder, and other accessories. The ra-
dial artery pulse wave signals can be detected by apply-
ing the sensor probe to the radial artery; these signals
are then amplified by the signal amplifier and transmit-
ted to the recorder. There they are drawn into pulse
curve, that is, the radial artery pulse waveform or
sphygmogram. Sphygmograms can be processed and
analyzed with Pulse Condition Processing Program
Version 3.0 (Shanghai University of TCM Science and
Technology Co., Ltd., Shanghai, China). In our study,
patients lay in the supine position with the left upper
arm extended. The probe was placed on the radial ar-
tery (Figure 3 for the specific location used to detect ra-
dial artery pulse waves), and the pressure knob was ro-
1
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Figure 1 Pump-setting diagram
1: start time (20% to 30% of the interval); 2: stop time (70%
to 80% of the interval); 3: interval between two r-waves
(100%); 4: base flow (20% to 30% of the equivalent continu-
ous flow); 5: peak flow (100%); 6: pulsatile flow (70% to 80%).
Flow
Time
1
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Figure 2 Schematic diagram of the sensor structure
1: probe; 2: pressure knob; 3: frame; 4: velcro.
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tated after velcro was affixed until pulse waves ap-
peared at their highest peak; the pulse wave graph was
then captured and recorded with the sphygmograph.
Arterial pulse waves of the upper body of humans gen-
erally comprise two or three upward wave groups, and
the arterial pulse waves of the lower body generally
comprise two upward waves;16 thus, radial artery pulse
waves generally comprise two or three upward wave
groups (including percussion wave, tidal wave, and di-
crotic wave) and one or two intervals (also called notch-
es) between each wave crest. In the sphygmogram (see
Figure 4 for sphygmogram physiological parameters),
the h1 value primarily reflects the ejection function of
the left ventricle. The sphygmogram's h3 value primari-
ly reflects arterial tension. The h4 value primarily re-
flects peripheral vascular resistance, and the h5 value
primarily denotes arterial compliance.
RESULTS
Radial arterial pulse waveforms could be detected in all
of the 34 patients before CPB (a representative sphyg-
mogram is shown in Figure 5), but no pulse wave-
forms could be detected at any of the 34 patients' radi-
al artery after aortic cross-clamping (representative
sphygmogram is shown in Figure 6). In the pulsatile
perfusion group, pulse waveforms could be detected at
all patients' radial artery during pulsatile perfusion;
however, the upward waves of the sphygmogram dur-
ing pulsatile perfusion were lower than those from be-
fore the operation (a representative sphygmogram is
shown in Figure 7). In the non-pulsatile perfusion
group, no pulse waveform could be detected at pa-
tients' radial artery during CPB (a representative sphyg-
mogram is shown in Figure 8).
DISCUSSION
By optimizing the experimental designs, we established
two different modes of perfusion (different types of
pulsatility). We found that pulse waveforms could be
detected with a sphygmogram apparatus at each pa-
Figure 3 Schematic diagram of the location used to detect
radial artery pulse
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Figure 4 Schematic diagram of the physiological parameters
of a pulse waveform
h1: the height of percussion wave; h3: the height of tidal
wave; h4: the height of notch; h5: the height of dicrotic
wave; t1: the time from starting point to percussion wave
vertex, t4: the time from starting point to notch, t5: the time
from notch to end point, t: the time from starting point to
end point, w: the width at the upper 1/3 of percussion
wave.
Figure 7 Pulse waveforms at patient's radial artery in the pul-
satile perfusion group
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Figure 5 Pulse waveforms at patients' radial artery before
CPB
P: the pulse-taking pressure, and the units for measuring
pressure are grams; CPB: cardiopulmonary bypass.
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Figure 6 Pulse waveforms at patients' radial artery after aor-
tic cross-clamping
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tient's radial artery during pulsatile perfusion proce-
dures. This finding means that a pulsatile pump can
generate more pulsatile energy, and that hemodynamic
energy can be delivered to the patients and be effective-
ly transmitted; however, a non-pulsatile pump does
not generate pulsatile flow. It also suggests that radial
arterial pulse waveforms can not only reflect the deliv-
ering conditions of hemodynamic energy of pulsatile
perfusion during CPB, but also be used as a quantifica-
tion method for defining pulsatile perfusion.
We discovered that pulse waveforms can be detected at
pulsatile perfusion patients' radial artery before and
during pulsatile perfusion; however, the upward waves
of patients' pulse waveforms during pulsatile perfusion
are lower than those taken before the operation. With
regard to a potential cause of this phenomenon, we
speculate that it might be related to the differences be-
tween the hemodynamic energy generated by the heart
and by the pulsatile pump, or it might be related to
some energy having been absorbed by the components
of the extracorporeal circuit during pulsatile perfusion
procedures.
Previous studies confirmed that the sphygmogram h1
value primarily reflects the ejection function of the left
ventricle and aortic compliance, and that h1 will rise
when the ejection function of the left ventricle
strengthens or aortic compliance increases, and vice ver-
sa. The h3 value primarily reflects arterial tension, and
h3 will rise when arterial tension increases, and vice
versa, or even disappears. The h4 value primarily
shows the state of the blood volume at the beginning
of diastole, and h4 will rise when arterial blood volume
increases at the beginning of diastole resulting from in-
creased peripheral resistance;17 h4 will reduce when cir-
culating blood volume or peripheral resistance decreas-
es.17,18 The h5 value primarily denotes arterial compli-
ance, as a reduction in such compliance will cause h5
to fall or become flat .The t1 value corresponds to the
time of rapid ejection of the left ventricle; the t4 value
approximately corresponds to the time of the systolic
phase; and the t5 value approximately corresponds to
the time of the diastolic phase. The t value corresponds
to the time of the cardiac cycle or sphygmus cycle. The
w value corresponds to the time required for the main-
tenance of high arterial pressure.
In addition to the physiological parameters noted
above, ratios such as those of h3/h1, h4/h1, h5/h1, w/
t, t1/t may reflect specific heart conditions of heart, ar-
terial systems, and blood flow more precisely and sensi-
tively.17 Taking these details into consideration, we
thus believe that the morphologies (shapes and sizes) of
pulse waveforms can be used as a valid indicator of the
effects of pulsatile perfusion during CPB.
Sphygmography can be used as a quantitative method
to observe the delivering effects of hemodynamic ener-
gy during pulsatile perfusion, and sphygmographic
morphologies can be used as an indicator to evaluate
the effectiveness of pulsatile perfusion during CPB.
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